In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol

This publication has 43 references indexed in Scilit:

• Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model
  International Journal of Cancer, 2007
• Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells
  American Journal of Physiology-Endocrinology and Metabolism, 2005
• Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity
  International Journal of Urology, 2005
• A Concentrated Aglycone Isoflavone Preparation (GCP) That Demonstrates Potent Anti-Prostate Cancer ActivityIn vitroandIn vivo
  Clinical Cancer Research, 2004
• Methylation and Inactivation of Estrogen, Progesterone, and Androgen Receptors in Prostate Cancer
  JNCI: Journal of the National Cancer Institute, 2002
• Expression of Estrogen Receptor (ER–α and ER–β) mRNA in Human Prostate Cancer
  European Urology, 2001
• Protein tyrosine kinase inhibitor, genistein, enhances apoptosis and cell cycle arrest in K562 cells treated with γ-irradiation
  Cancer Letters, 2000
• Expression of Estrogen Receptor α and β mRNAs in Prostate Cancers Treated with Leuprorelin Acetate
  European Urology, 2000
• Genistein‐induced upregulation of p21^WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells
  Nutrition and Cancer, 1998
• Radiosensitivity of human breast cancer cell lines of different hormonal responsiveness. Modulatory effects of oestradiol
  International Journal of Radiation Biology, 1996